Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
D

Failure to Obtain and Document Consent for Psychotropic Medications

Bastrop, Louisiana Survey Completed on 02-11-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure residents were fully informed about and consented to psychotropic medication treatment. For one resident admitted with multiple complex conditions including acute and chronic respiratory failure, diabetes with chronic kidney disease, dysphagia and hemiplegia following cerebral infarction, secondary malignant neoplasm of the large intestine and rectum, peripheral vascular disease, ischemic cardiomyopathy, and hypertension, the admission MDS showed a BIMS score of 11, indicating moderate cognitive impairment with daily decision-making ability. This resident was receiving the psychotropic medication Zoloft 25 mg daily via PEG tube for major depressive disorder, initiated by physician order on 12/08/2025 and administered daily in January 2026 as documented on the MAR. On 02/11/2026, an LPN confirmed there was no documentation in the medical record to support that consent for Zoloft had been obtained. The facility also failed to obtain documented consent for psychotropic medication for another resident admitted with hemiplegia and hemiparesis following cerebral infarction affecting the right dominant side, type 2 diabetes mellitus without complications, atherosclerotic heart disease of native coronary artery without angina pectoris, bipolar disorder, hyperlipidemia, and anemia. The annual MDS showed a BIMS score of 6, indicating severe cognitive impairment with daily decision-making. This resident was receiving Abilify 2.5 mg by mouth daily for bipolar disorder, initiated by physician order on 07/21/2025 and administered daily in January 2026, except during hospitalization, as shown on the MAR. On 02/11/2026, an RN confirmed there was no documentation in the medical record to support that consent for Abilify had been obtained. These findings show the facility did not address the residents’ right to be informed in advance of the risks and benefits of psychotropic medication treatment and to provide consent.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙